Organon & Co.

OGN US Health Care Pharmaceuticals
S&P 600
$13.64
+0.07%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Return on equity is healthy at 18.6%.
  • Current assets comfortably cover current liabilities (current ratio 1.82).
  • Has paid a dividend in each of the last 5 years on record.

!Watch-points

  • Higher leverage: debt-to-equity of 8.59 is above 1.
  • Thin interest cover: operating profit covers interest only about 0.8 times.
  • Return on capital employed is on the lower side at 3.9%.
  • Net profit margin is slim at 3%.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
1.07

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Piotroski F-ScoreModerate
5 / 8

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 8 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap$3.58B
Current Price$ 13.64
High / Low$ 13.79 / 5.69
Stock P/E17.48718
Book Value$ 3.72
Dividend Yield0.59%
ROCE3.94%
ROE18.59%
Debt to Equity8.59
Current Ratio1.82
P/B Ratio3.5604281
EPS$ 0.72
Debt$8.64B
PAT Margin3.01%
Cash PAT$343.00M
ICR0.84
Educational data only. Not a recommendation to buy, sell or hold any security.